# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Evotec is entitled to receive double-digit royalties of net sales as well as milestones based on commercial success and further...
Reuters
The U.S.
Evotec and Bristol Myers Squibb entered their strategic protein degradation partnership in 2018 and expanded it in May of 202...
Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX)(OTC: EVOTF)(NASDAQ: EVO) today announced that the U.S. Department of Defe...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Clinical data builds upon body of evidence suggesting EXS-21546 is a highly potent and selective A2AR antagonist with low CNS e...
Bayer AG (OTC: BAYRY) has